Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II trial expanded for Aronex's renal cell carcinoma product

Sep. 13, 1999

U.S. and Canadian academics design novel prodrug approach to 5-FU chemotherapy

Sep. 10, 1999

Roche to submit sNDA for Xeloda as first-line colorectal cancer therapy

Sep. 10, 1999

Israeli group designs new family of nonpeptide, nonsulfhydryl Ras farnesylation inhibitors

Sep. 9, 1999

Atairgin and Washington State University to develop new therapeutic applications

Sep. 9, 1999

Roberts to market Fareston in the U.S.

Sep. 9, 1999

Full agenda for next week's Oncologic Drugs Advisory Committee meeting

Sep. 9, 1999

Topoisomerase poisons emerge from research at U.S. university

Sep. 9, 1999

RPR reports new naphthyl-piperazinone antitumor agents

Sep. 9, 1999

Kirin Brewery reports SAR in the area of Fas/FAP-1 binding inhibitors

Sep. 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...